Cary Street Partners Asset Management’s Amgen AMGN Stock Holding History

Cary Street Partners Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$1.84K	–	399
2022 Q4	$1.84K	Sell	7 -62	-90%	-$16.6K	﹤0.01%	421
2022 Q3	$15K	Buy	+69	New	+$16.7K	﹤0.01%	301
2021 Q2	–	Sell	-19,483	Closed	-$223K	–	160
2021 Q1	$223K	Buy	19,483 +1,477	+8%	+$352K	0.05%	163
2020 Q4	$192K	Buy	+18,006	New	+$4.15M	0.06%	154

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cary Street Partners Asset Management's AMGN Position: Q1 2023 in Review

Cary Street Partners Asset Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 7 shares — an estimated $1.84K sold.

Cary Street Partners Asset Management first reported a position in AMGN in Q4 2020 and held it in 4 quarters. The position peaked at $223K in Q1 2021. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

Cary Street Partners Asset Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
Cary Street Partners Asset Management sold 7 Amgen shares in Q1 2023, an estimated $1.84K.
Cary Street Partners Asset Management first reported a position in Amgen in Q4 2020 and held it in 4 quarters.
Cary Street Partners Asset Management's Amgen position peaked at $223K in Q1 2021.
2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q1 2023, filed 12 May 2023.